Clinical Trial: A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Study Type: INTERVENTIONAL
Official Title: A Randomized, Open-Label, Phase II Trial of Nab-paclitaxel + Gemcitabine With or Without Botensilimab (AGEN1181) in Patients With Metastatic Pancreatic Cancer Who Have Progressed on Prior 5FU + Leucov
Brief Summary:
The goal of this clinical trial is to test if the addition of botensilimab to standard chemotherapy improves the efficacy compared to just chemotherapy alone in participants with metastatic pancreatic cancer.One group of participants will only receive chemotherapy while a second group of participants will receive botensilimab and chemotherapy.
Read more